Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Safety data from trials In a paper summarizing 6 randomized, double-blind, placebo-controlled human trials, AOD 9604 did not significantly affect IGF-1 levels, did not impair glucose tolerance, and no serious adverse events (SAEs) were attributed to AOD 9604
It may still look like a clear solution or a white powder, but it no longer does what it was prescribed to do
Our BPC-157 drops are intended strictly for research purposes only and are not approved for human or veterinary use
Later work has built on that finding, including a 2023 peer-reviewed review on MOTS-Cs role in metabolic disorders
It suggests BPC-157 could improve benzodiazepine efficacy during chronic treatment, potentially allow lower therapeutic doses, and ease withdrawal when discontinuing benzodiazepines
Supports Precise Reconstitution Supports Precise Reconstitution Provides a clean, measured solution to support controlled reconstitution in standard research procedures
